SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Urania Georgopoulou, Alexios Dimitriadis, Pelagia Foka, Eirini Karamichali, Avgi Mamalaki, Hepcidin and the iron enigma in HCV infection, Virulence, 2014, 5, 4, 465

    CrossRef

  2. 2
    Katarzyna Sikorska, Agnieszka Bernat, Iron homeostasis and its regulators over the course of chronic hepatitis C, Future Virology, 2014, 9, 9, 831

    CrossRef

  3. 3
    KASL clinical practice guidelines: Management of Hepatitis C, Clinical and Molecular Hepatology, 2014, 20, 2, 89

    CrossRef

  4. 4
    W. H. Horl, A. Schmidt, Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C, Nephrology Dialysis Transplantation, 2014, 29, 6, 1141

    CrossRef

  5. 5
    Albert Altés, Maria José Pérez-Lucena, Miquel Bruguera, Sistemática diagnóstica en la hiperferritinemia, Medicina Clínica, 2014, 142, 9, 412

    CrossRef

  6. 6
    Alexander Ivanov, Birke Bartosch, Olga Smirnova, Maria Isaguliants, Sergey Kochetkov, HCV and Oxidative Stress in the Liver, Viruses, 2013, 5, 2, 439

    CrossRef

  7. 7
    Yusuke Suzuki, Kenji Imai, Koji Takai, Tatsunori Hanai, Hideki Hayashi, Takafumi Naiki, Yoichi Nishigaki, Eiichi Tomita, Masahito Shimizu, Hisataka Moriwaki, Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test, Journal of Cancer Research and Clinical Oncology, 2013, 139, 5, 845

    CrossRef

  8. 8
    Ayten Oguz, Ahmet Engin Atay, Adnan Tas, Gulseren Seven, Mehmet Koruk, Predictive Role of Acute Phase Reactants in the Response to Therapy in Patients with Chronic Hepatitis C Virus Infection, Gut and Liver, 2013, 7, 1, 82

    CrossRef

  9. 9
    Kenichiro Yasutake, Motoyuki Kohjima, Manabu Nakashima, Kazuhiro Kotoh, Makoto Nakamuta, Munechika Enjoji, Clinical Nutrition, 2013,

    CrossRef

  10. 10
    Carmine Mancone, Claudia Montaldo, Laura Santangelo, Cristina Di Giacomo, Viviana Costa, Laura Amicone, Giuseppe Ippolito, Leopoldo Paolo Pucillo, Tonino Alonzi, Marco Tripodi, Ferritin Heavy Chain Is the Host Factor Responsible for HCV-Induced Inhibition of apoB-100 Production and Is Required for Efficient Viral Infection, Journal of Proteome Research, 2012, 11, 5, 2786

    CrossRef

  11. 11
    Jinah Choi, Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations, Free Radical Biology and Medicine, 2012, 52, 7, 1135

    CrossRef

  12. 12
    Christian M. Lange, Zoltan Kutalik, Kenichi Morikawa, Stéphanie Bibert, Andreas Cerny, Günter Dollenmaier, Jean-François Dufour, Tilman J. Gerlach, Markus H. Heim, Raffaele Malinverni, Beat Müllhaupt, Francesco Negro, Darius Moradpour, Pierre-Yves Bochud, Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy, Hepatology, 2012, 55, 4
  13. 13
    Ya-Lin Chiou, Yi-Hui Chen, Tiffany Ke, Wang-Sheng Ko, The effect of increased oxidative stress and ferritin in reducing the effectiveness of therapy in chronic hepatitis C patients, Clinical Biochemistry, 2012, 45, 16-17, 1389

    CrossRef

  14. 14
    Hersh Chandarana, Richard K. G. Do, Thais C. Mussi, Jens H. Jensen, Cristina H. Hajdu, James S. Babb, Bachir Taouli, The Effect of Liver Iron Deposition on Hepatic Apparent Diffusion Coefficient Values in Cirrhosis, American Journal of Roentgenology, 2012, 199, 4, 803

    CrossRef

  15. 15
    Tusar K. Desai, Jared Bortman, Rasm Al-Sibae, Herbert Bonkovsky, The Role of Iron in Hepatitis C Infection, Current Hepatitis Reports, 2012, 11, 1, 41

    CrossRef

  16. 16
    Maria Guido, Alessandra Mangia, Gavino Faa, Chronic viral hepatitis: The histology report, Digestive and Liver Disease, 2011, 43, S331

    CrossRef

  17. 17
    Mohamed Nageeb Rashed, The role of trace elements on hepatitis virus infections: A review, Journal of Trace Elements in Medicine and Biology, 2011, 25, 3, 181

    CrossRef

  18. 18
    Tarun K. Narang, Hossein Sendi, Martin W. Scobey, Herbert L. Bonkovsky, Iron and Hepatitis C, Current Hepatitis Reports, 2010, 9, 3, 169

    CrossRef

  19. 19
    Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi, Masatoshi Kudo, Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009), Hepatology Research, 2010, 40, 4
  20. 20
    Seyed-Moayed Alavian, Seyed-Vahid Tabatabaei, Therapy of hepatitis C in thalassemia: the influence of iron on achieving sustained viral response, Annals of Hematology, 2010, 89, 2, 215

    CrossRef

  21. 21
    Mohamed Nageeb Rashed, Mahasen Mohamed Ahmed, Ahmed Farouk Al-Hossainy, Safaa Mahmoud Abd, Trends in speciation analysis of some heavy metals in serum of patients with chronic hepatitis C and chronic hepatitis B using differential pulse adsorptive stripping voltammetric measurement and atomic absorption spectrophotometry, Journal of Trace Elements in Medicine and Biology, 2010, 24, 2, 138

    CrossRef

  22. You have free access to this content22
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
  23. 23
    Ivan Gentile, Chiara Viola, Luigi Paesano, Marcello D'Onofrio, Elio D'Agostino, Raimondo Cerini, Francesco Borrelli, Marcello Piazza, Guglielmo Borgia, Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial, Journal of Clinical Apheresis, 2009, 24, 5
  24. 24
    Domenico Girelli, Michela Pasino, Julia B. Goodnough, Elizabeta Nemeth, Maria Guido, Annalisa Castagna, Fabiana Busti, Natascia Campostrini, Nicola Martinelli, Italo Vantini, Roberto Corrocher, Tomas Ganz, Giovanna Fattovich, Reduced serum hepcidin levels in patients with chronic hepatitis C, Journal of Hepatology, 2009, 51, 5, 845

    CrossRef

  25. 25
    M. KAY WASHINGTON, Modern Surgical Pathology, 2009,

    CrossRef

  26. 26
    ELIZABETH I. HARRIS, KAY WASHINGTON, LAURA W. LAMPS, Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas, 2009,

    CrossRef

  27. 27
    Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote, Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors, Gastroenterology, 2008, 134, 6, 1699

    CrossRef

  28. 28
    Y. PAN, R. T. JACKSON, Ethnic difference in the relationship between acute inflammation and serum ferritin in US adult males, Epidemiology and Infection, 2008, 136, 03

    CrossRef

  29. 29
    Debbie Trinder, Oyekoya T. Ayonrinde, John K. Olynyk, HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin, Gastroenterology, 2008, 134, 1, 348

    CrossRef

  30. 30
    Kouichi Miura, Kojiro Taura, Yuzo Kodama, Bernd Schnabl, David A. Brenner, Hepatitis C virus–induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity, Hepatology, 2008, 48, 5
  31. 31
    Tusar K. Desai, Laith H. Jamil, Mamtha Balasubramaniam, Raymond Koff, Herbert L. Bonkovsky, Phlebotomy Improves Therapeutic Response to Interferon in Patients with Chronic Hepatitis C: A Meta-Analysis of Six Prospective Randomized Controlled Trials, Digestive Diseases and Sciences, 2008, 53, 3, 815

    CrossRef

  32. 32
    Julie M. Bares, Jose Berger, James E. Nelson, Donald J. Messner, Sandra Schildt, Leanna J. Standish, Kris V. Kowdley, Silybin Treatment is Associated With Reduction in Serum Ferritin in Patients With Chronic Hepatitis C, Journal of Clinical Gastroenterology, 2008, 42, 8, 937

    CrossRef

  33. 33
    Massimo Franchini, Giovanni Targher, Franco Capra, Martina Montagnana, Giuseppe Lippi, The effect of iron depletion on chronic hepatitis C virus infection, Hepatology International, 2008, 2, 3, 335

    CrossRef

  34. 34
    Jacob Alexander, Bruce Y. Tung, Anne Croghan, Kris V. Kowdley, Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study, Liver International, 2007, 27, 2
  35. 35
    Carine Fillebeen, Martina Muckenthaler, Bill Andriopoulos, Martin Bisaillon, Zineb Mounir, Matthias W. Hentze, Antonis E. Koromilas, Kostas Pantopoulos, Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells, Journal of Hepatology, 2007, 47, 1, 12

    CrossRef

  36. 36
    Naoki Fujita, Ryosuke Sugimoto, Naohito Urawa, Jun Araki, Rumi Mifuji, Mika Yamamoto, Shinichiro Horiike, Hideaki Tanaka, Motoh Iwasa, Yoshinao Kobayashi, Yukihiko Adachi, Masahiko Kaito, Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C, Journal of Gastroenterology and Hepatology, 2007, 22, 11
  37. 37
    Naoki Fujita, Shinichiro Horiike, Ryosuke Sugimoto, Hideaki Tanaka, Motoh Iwasa, Yoshinao Kobayashi, Koji Hasegawa, Ning Ma, Shosuke Kawanishi, Yukihiko Adachi, Masahiko Kaito, Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients, Free Radical Biology and Medicine, 2007, 42, 3, 353

    CrossRef

  38. 38
    María Elena Luna-Morales, Francisco Collazo-Reyes, Historic and bibliometric analysis of the Latin American and Caribbean journals in the international Science Indexes: 1961-2005, Revista española de Documentación Científica, 2007, 30, 4

    CrossRef

  39. 39
    Tahereh Ghaziani, Seyed-Moayed Alavian, Mohammad R. Zali, Saeid Shahraz, Mohammdreza Agah, Kevin P. Jensen, Shahin Ansari, Hossein Sendi, Richard W. Lambrecht, Jonathan Covault, Herbert L. Bonkovsky, Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection, Hepatology Research, 2007, 37, 3
  40. 40
    Jacob Alexander, Kris V. Kowdley, Effects of Iron and HFE Mutations on Response to Therapy in Chronic Hepatitis C: An Ironic Interaction?, Gastroenterology, 2006, 131, 5, 1635

    CrossRef

  41. 41
    Jordan J. Feld, T. Jake Liang, Hepatitis C — identifying patients with progressive liver injury, Hepatology, 2006, 43, S1
  42. 42
    Stanislas Pol, Vincent O Mallet, Improving anti-hepatitis C virus therapy, Expert Opinion on Biological Therapy, 2006, 6, 9, 923

    CrossRef

  43. 43
    Herbert L. Bonkovsky, Deepa Naishadham, Richard W. Lambrecht, Raymond T. Chung, John C. Hoefs, S. Russell Nash, Thomas E. Rogers, Barbara F. Banner, Richard K. Sterling, John A. Donovan, Robert J. Fontana, Adrian M. Di Bisceglie, Marc G. Ghany, Chihiro Morishima, Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C, Gastroenterology, 2006, 131, 5, 1440

    CrossRef

  44. 44
    NEKTARIOS SOUBASIS, TIMOLEON S RALLIS, JOHN VLEMMAS, KATERINA K ADAMAMA-MORAITOU, NIKOLAOS ROUBIES, NIKITAS N PRASSINOS, GEORGIA BRELLOU, Serum and liver iron concentration in dogs with experimentally induced hepatopathy, Journal of Gastroenterology and Hepatology, 2006, 21, 3
  45. 45
    Fabio Tinè, Massimo Attanasio, Francesca Russo, Luigi Pagliaro, A decade of trials of interferon-alpha for chronic hepatitis C. A meta-regression analysis, Contemporary Clinical Trials, 2005, 26, 2, 179

    CrossRef

  46. 46
    Y. Shan, R. W. Lambrecht, H. L. Bonkovsky, Association of Hepatitis C Virus Infection with Serum Iron Status: Analysis of Data from the Third National Health and Nutrition Examination Survey, Clinical Infectious Diseases, 2005, 40, 6, 834

    CrossRef

  47. 47
    Yusuke Kawamura, Norio Akuta, Hitomi Sezaki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada, Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection, Journal of Gastroenterology, 2005, 40, 9, 901

    CrossRef

  48. 48
    Serkan Kahraman, Rahmi Yilmaz, Gultekin Genctoy, Mustafa Arici, Bulent Altun, Yunus Erdem, Unal Yasavul, Cetin Turgan, Efficacy and Safety of Intravenous Iron Therapy for HCV-Positive Haemodialysis Patients, Nephron Clinical Practice, 2005, 100, 3, c78

    CrossRef

  49. 49
    C. Rigamonti, S. Andorno, E. Maduli, F. Capelli, R. Boldorini, M. Sartori, Gender and liver fibrosis in chronic hepatitis: the role of iron status, Alimentary Pharmacology & Therapeutics, 2005, 21, 12
  50. 50
    Peter W. M. Dienhart, Richard K. Sterling, Management of hepatitis C virus in patients with porphyria cutanea tarda, Current Hepatitis Reports, 2005, 4, 3, 104

    CrossRef

  51. 51
    Kazuhiro Hayashida, Akito Daiba, Akito Sakai, Takeshi Tanaka, Kyosuke Kaji, Niro Inaba, Satoshi Ando, Naoki Kajiyama, Hiroshi Terasaki, Aki Abe, Masanori Ogasawara, Michinori Kohara, Mine Harada, Takeshi Okanoue, Satoru Ito, Shuichi Kaneko, Pretreatment Prediction of Interferon-Alfa Efficacy in Chronic Hepatitis C Patients, Clinical Gastroenterology and Hepatology, 2005, 3, 12, 1253

    CrossRef

  52. 52
    Stephen J. Rulyak, Sue C. Eng, Keyur Patel, John G. McHutchison, Stuart C. Gordon, Kris V. Kowdley, Relationships between Hepatic Iron Content and Virologic Response in Chronic Hepatitis C Patients Treated with Interferon and Ribavirin, The American Journal of Gastroenterology, 2005, 100, 2, 332

    CrossRef

  53. 53
    Darko Nozic, Bela Balint, Nebojsa Stankovic, Jovan Dimitrijevic, Gorana Neskovic, Significance of iron reduction for the therapy of chronic hepatitis C, Vojnosanitetski pregled, 2005, 62, 2, 161

    CrossRef

  54. 54
    Robert J Fontana, Gregory T Everson, Sony Tuteja, Hugo E Vargas, Mitchell L Shiffman, Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis, Clinical Gastroenterology and Hepatology, 2004, 2, 3, 183

    CrossRef

  55. 55
    Motoh Iwasa, Kazuko Iwata, Masahiko Kaito, Jiro Ikoma, Mika Yamamoto, Masaki Takeo, Makoto Kuroda, Naoki Fujita, Yoshinao Kobayashi, Yukihiko Adachi, Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus, Nutrition, 2004, 20, 4, 368

    CrossRef

  56. 56
    James E. Nelson, Kris V. Kowdley, Iron and hepatitis C, Current Hepatitis Reports, 2004, 3, 4, 140

    CrossRef

  57. 57
    Christoph Eisenbach, Sven G. Gehrke, Wolfgang Stremmel, Iron, the HFE gene, and hepatitis C, Clinics in Liver Disease, 2004, 8, 4, 775

    CrossRef

  58. 58
    ANA LC MARTINELLI, ANTONIO B ARAUJO FILHO, RENDRIK F FRANCO, MARLI H TAVELLA, LEANDRA NZ RAMALHO, SERGIO ZUCOLOTO, SANDRA S RODRIGUES, MARCOS A ZAGO, Liver iron deposits in hepatitis B patients: Association with severity of liver disease but not with hemochromatosis gene mutations, Journal of Gastroenterology and Hepatology, 2004, 19, 9
  59. 59
    Robert J. Fontana, Nonresponders to hepatitis C virus antiviral therapy: pegylated interferons and beyond, Gastroenterology Clinics of North America, 2004, 33, 3, 527

    CrossRef

  60. 60
    Antonello Pietrangelo, Hemochromatosis gene modifies course of hepatitis C viral infection, Gastroenterology, 2003, 124, 5, 1509

    CrossRef

  61. 61
    Luis S. Marsano, Hepatitis, Primary Care: Clinics in Office Practice, 2003, 30, 1, 81

    CrossRef

  62. 62
    Andreas Erhardt, Andrea Maschner-Olberg, Claudia Mellenthin, Günther Kappert, Ortwin Adams, Andreas Donner, Reinhard Willers, Claus Niederau, Dieter Häussinger, HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis, Journal of Hepatology, 2003, 38, 3, 335

    CrossRef

  63. 63
    Herbert L. Bonkovsky, Richard W. Lambrecht, Ying Shan, Iron as a co-morbid factor in nonhemochromatotic liver disease, Alcohol, 2003, 30, 2, 137

    CrossRef

  64. 64
    Gary M. Brittenham, Iron chelators and iron toxicity, Alcohol, 2003, 30, 2, 151

    CrossRef

  65. 65
    Hari H Diwakaran, Alex S Befeler, Robert S Britton, Elizabeth M Brunt, Bruce R Bacon, Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection, Journal of Hepatology, 2002, 36, 5, 687

    CrossRef

  66. 66
    DIALYSIS CLINIC: Is Intravenous Iron Safe in Patients With Liver Disease?, Seminars in Dialysis, 2002, 15, 3
  67. 67
    C A Sherrington, J K Olynyk, Editorial, Liver, 2002, 22, 3
  68. 68
    Stephen Pianko, John G. McHutchison, Stuart C. Gordon, Shanon Heaton, Zachary D. Goodman, Keyur Patel, Cherise M. Cortese, Elizabeth M. Brunt, Bruce R. Bacon, Lawrence M. Blatt, Hepatic Iron Concentration Does Not Influence Response to Therapy with Interferon Plus Ribavirin in Chronic HCV Infection, Journal of Interferon & Cytokine Research, 2002, 22, 4, 483

    CrossRef

  69. 69
    William Sievert, Stephen Pianko, Sherryne Warner, Scott Bowden, Ian Simpson, Don Bowden, Stephen Locarnini, Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major, The American Journal of Gastroenterology, 2002, 97, 4, 982

    CrossRef

  70. 70
    Herbert L Bonkovsky, Nicole Troy, Kristina McNeal, Barbara F Banner, Ashish Sharma, Jorge Obando, Savant Mehta, Raymond S Koff, Qin Liu, Chung-Cheng Hsieh, Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C, Journal of Hepatology, 2002, 37, 6, 848

    CrossRef

  71. 71
    Bruno Turlin, Yves Deugnier, Iron overload disorders, Clinics in Liver Disease, 2002, 6, 2, 481

    CrossRef

  72. 72
    Silvia Fargion, Anna Ludovica Fracanzani, Angelo Rossini, Mauro Borzio, Oliviero Riggio, Giovanni Belloni, Franco Bissoli, Roberto Ceriani, Marco Ballare, Marco Massari, Caterina Trischitta, Pierluigi Fiore, Anna Orlandi, Lorenzo Morini, Michela Mattioli, Silvia Oldani, Bruno Cesana, Gemino Fiorelli, Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study, The American Journal of Gastroenterology, 2002, 97, 5, 1204

    CrossRef

  73. 73
    C. Rigamonti, S. Andorno, E. Maduli, S. Morelli, S. Pittau, G. Nicosia, R. Boldorini, M. Sartori, Iron, hepatic stellate cells and fibrosis in chronic hepatitis C, European Journal of Clinical Investigation, 2002, 32,
  74. 74
    Sanjay Agrawal, Herbert L. Bonkovsky, Management of Nonalcoholic Steatohepatitis, Journal of Clinical Gastroenterology, 2002, 35, 3, 253

    CrossRef

  75. 75
    Bruce R. Bacon, Hemochromatosis: Diagnosis and management, Gastroenterology, 2001, 120, 3, 718

    CrossRef

  76. 76
    Herbert L. Bonkovsky, Savant Mehta, Hepatitis C: A review and update, Journal of the American Academy of Dermatology, 2001, 44, 2, 159

    CrossRef

  77. 77
    Herbert L. Bonkovsky, Savant Mehta, Hepatitis C: A review and update, Disease-a-Month, 2001, 47, 12, 610

    CrossRef

  78. 78
    Honggang Wang, Koji Nishiya, Hiroyuki Ito, Takanori Hosokawa, Kozo Hashimoto, Toshiaki Moriki, Iron deposition in renal biopsy specimens from patients with kidney diseases, American Journal of Kidney Diseases, 2001, 38, 5, 1038

    CrossRef

  79. 79
    Edoardo Giannini, Luca Mastracci, Federica Botta, Paola Romagnoli, Alberto Fasoli, Domenico Risso, Francesca Faravelli, Paola Ceppa, Pasquale B. Lantieri, Gian Carlo Icardi, Roberto Testa, Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and α-glutathione S-transferase levels, European Journal of Gastroenterology & Hepatology, 2001, 13, 11, 1355

    CrossRef

  80. 80
    Rafael Amaro, Eugene R. Schiff, Viral hepatitis, Current Opinion in Gastroenterology, 2001, 17, 3, 262

    CrossRef

  81. 81
    Mark Wright, Janice Main, The prevention and management of viral hepatitis, Current Opinion in Infectious Diseases, 2000, 13, 5, 489

    CrossRef

  82. 82
    Bruce R. Bacon, Robert S. Britton, Hemochromatosis and Iron Storage Disorders,
  83. 83
    Jama M. Darling, Stanley M. Lemon, Michael W. Fried, Hepatitis C,